LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
16,084,261
Share change
+5,210,671
Total reported value
$446,797,865
Put/Call ratio
41%
Price per share
$27.79
Number of holders
72
Value change
+$144,681,607
Number of buys
53
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q3 2015

As of 30 Sep 2015, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,084,261 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, FMR LLC, Broadfin Capital, LLC, RTW INVESTMENTS, LLC, FRANKLIN RESOURCES INC, JANUS CAPITAL MANAGEMENT LLC, venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, Visium Asset Management, LP, and Allianz Asset Management AG. This page lists 72 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.